The prostaglandin D 2 receptor 2 pathway in asthma: a key player in airway inflammation
Domingo, Christian, Palomares, Oscar, Sandham, David A, Erpenbeck, Veit J, Altman, Pablo
Published in Respiratory research (29.09.2018)
Published in Respiratory research (29.09.2018)
Get full text
Journal Article
The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
Domingo, Christian, Palomares, Oscar, Sandham, David A, Erpenbeck, Veit J, Altman, Pablo
Published in Respiratory research (29.09.2018)
Published in Respiratory research (29.09.2018)
Get full text
Journal Article
Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
Werfel, Thomas, MD, Heratizadeh, Annice, MD, Niebuhr, Margarete, MD, Kapp, Alexander, MD, Roesner, Lennart Matthias, PhD, Karch, Annika, MSc, Erpenbeck, Veit J., MD, PhD, Lösche, Christian, MD, Jung, Thomas, MD, Krug, Norbert, MD, Badorrek, Philipp, MD, Hohlfeld, Jens M., MD
Published in Journal of allergy and clinical immunology (01.07.2015)
Published in Journal of allergy and clinical immunology (01.07.2015)
Get full text
Journal Article
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
Erpenbeck, Veit J, Popov, Todor A, Miller, David, Weinstein, Steven F, Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Published in Pulmonary pharmacology & therapeutics (01.08.2016)
Published in Pulmonary pharmacology & therapeutics (01.08.2016)
Get full text
Journal Article
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
Metz, Martin, Staubach, Petra, Bauer, Andrea, Brehler, Randolf, Gericke, Janine, Kangas, Michael, Ashton-Chess, Joanna, Jarvis, Philip, Georgiou, Panayiotis, Canvin, Janice, Hillenbrand, Rainer, Erpenbeck, Veit J, Maurer, Marcus
Published in Theranostics (01.01.2017)
Published in Theranostics (01.01.2017)
Get full text
Journal Article
Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD
Winkler, Carla, Atochina-Vasserman, Elena N, Holz, Olaf, Beers, Michael F, Erpenbeck, Veit J, Krug, Norbert, Roepcke, Stefan, Lauer, Gereon, Elmlinger, Martin, Hohlfeld, Jens M
Published in Respiratory research (11.03.2011)
Published in Respiratory research (11.03.2011)
Get full text
Journal Article
Omalizumab in asthma: an update on recent developments
Humbert, Marc, Busse, William, Hanania, Nicola A, Lowe, Philip J, Canvin, Janice, Erpenbeck, Veit J, Holgate, Stephen
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01.09.2014)
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01.09.2014)
Get more information
Journal Article
Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study
Metz, Martin, Torene, Rebecca, Kaiser, Sergio, Beste, Michael T., Staubach, Petra, Bauer, Andrea, Brehler, Randolf, Gericke, Janine, Letzkus, Martin, Hartmann, Nicole, Erpenbeck, Veit J., Maurer, Marcus
Published in Allergy (Copenhagen) (01.01.2019)
Published in Allergy (Copenhagen) (01.01.2019)
Get full text
Journal Article
Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor
Carstensen, Saskia, Gress, Christina, Erpenbeck, Veit J, Kazani, Shamsah D, Hohlfeld, Jens M, Sandham, David A, Müller, Meike
Published in Respiratory research (07.10.2021)
Published in Respiratory research (07.10.2021)
Get full text
Journal Article
Fevipiprant, a selective prostaglandin D 2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Hardman, Clare, Chen, Wentao, Luo, Jian, Batty, Paul, Chen, Yi-Ling, Nahler, Janina, Wu, Yanqiu, Pavord, Ian D, Erpenbeck, Veit J, Sandham, David A, Xue, Luzheng, Ogg, Graham
Published in Journal of allergy and clinical immunology (01.06.2019)
Published in Journal of allergy and clinical immunology (01.06.2019)
Get full text
Journal Article
A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach
Weiss, H Markus, Umehara, Ken-Ichi, Erpenbeck, Veit J, Cain, Meredith, Vemula, Janardhana, Elbast, Walid, Zollinger, Markus
Published in Drug metabolism and disposition (01.10.2020)
Published in Drug metabolism and disposition (01.10.2020)
Get full text
Journal Article
The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure
Schleh, Carsten, Mühlfeld, Christian, Pulskamp, Karin, Schmiedl, Andreas, Nassimi, Matthias, Lauenstein, Hans D, Braun, Armin, Krug, Norbert, Erpenbeck, Veit J, Hohlfeld, Jens M
Published in Respiratory research (30.09.2009)
Published in Respiratory research (30.09.2009)
Get full text
Journal Article
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Hardman, Clare, Chen, Wentao, Luo, Jian, Batty, Paul, Chen, Yi-Ling, Nahler, Janina, Wu, Yanqiu, Pavord, Ian D., Erpenbeck, Veit J., Sandham, David A., Xue, Luzheng, Ogg, Graham
Published in Journal of allergy and clinical immunology (01.06.2019)
Published in Journal of allergy and clinical immunology (01.06.2019)
Get full text
Journal Article
U-BIOPRED: evaluation of the value of a public–private partnership to industry
Riley, John H., Erpenbeck, Veit J., Matthews, John G., Holweg, Cecile T.J., Compton, Christopher, Seibold, Wolfgang, Higenbottam, Timothy, Wagers, Scott, Rowe, Anthony, Myles, David
Published in Drug discovery today (01.09.2018)
Published in Drug discovery today (01.09.2018)
Get full text
Journal Article
Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table
Kornmann, Oliver, Watz, Henrik, Fuhr, Rainard, Krug, Norbert, Erpenbeck, Veit J, Kaiser, Guenther
Published in Pulmonary pharmacology & therapeutics (01.08.2014)
Published in Pulmonary pharmacology & therapeutics (01.08.2014)
Get full text
Journal Article
Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro
Pearson, David, Weiss, H Markus, Jin, Yi, Jaap van Lier, Jan, Erpenbeck, Veit J, Glaenzel, Ulrike, End, Peter, Woessner, Ralph, Eggimann, Fabian, Camenisch, Gian
Published in Drug metabolism and disposition (01.07.2017)
Published in Drug metabolism and disposition (01.07.2017)
Get full text
Journal Article
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism
Chen, Wentao, Luo, Jian, Ye, Yuan, Hoyle, Ryan, Liu, Wei, Borst, Rowie, Kazani, Shamsah, Shikatani, Eric A., Erpenbeck, Veit J., Pavord, Ian D., Klenerman, Paul, Sandham, David A., Xue, Luzheng
Published in The Journal of immunology (1950) (01.06.2021)
Published in The Journal of immunology (1950) (01.06.2021)
Get full text
Journal Article